UNITES
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in its Charter)
(State or other jurisdiction of incorporation) | (Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices, including ZIP code)
(Registrant’s telephone number, including area code)
n/a
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 19, 2022, Nephros, Inc. (the “Company”) held its 2022 Annual Meeting of the Stockholders (the “Annual Meeting”). At the Annual Meeting:
1. | Stockholders elected to the Company’s Board of Directors two nominees, Andrew Astor and Alisa Lask, to each serve a three-year term expiring in 2025; | |
2. | Stockholders ratified the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022; and | |
3. | Stockholders approved the compensation of the Company’s named executive officers on an advisory (non-binding) basis. |
The voting results for each such matter were as follows:
1. | Election of Directors: |
Nominee: | For: | Withheld: | Broker Non-Votes: | |||||||||
Andrew Astor | 6,189,006 | 134,108 | 2,333,049 | |||||||||
Alisa Lask | 6,192,377 | 130,737 | 2,333,049 |
2. | Ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022: |
For: | Against: | Abstain: | Broker Non-Votes | |||||||||||
8,637,438 | 17,548 | 1,177 | 0 |
3. | Approval of the compensation of the Company’s named executive officers on an advisory (non-binding) basis: |
For: | Against: | Abstain: | Broker Non-Votes | |||||||||||
6,093,819 | 216,653 | 12,642 | 2,333,049 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Nephros, Inc. | ||
Dated: May 20, 2022 | By: | /s/ Andrew Astor |
Andrew Astor | ||
Chief Executive Officer |
Cover |
May 19, 2022 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | May 19, 2022 |
Entity File Number | 001-32288 |
Entity Registrant Name | NEPHROS, INC. |
Entity Central Index Key | 0001196298 |
Entity Tax Identification Number | 13-3971809 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 380 Lackawanna Place, |
Entity Address, City or Town | South Orange, |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 07079 |
City Area Code | (201) |
Local Phone Number | 343-5202 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, $0.001 par value |
Trading Symbol | NEPH |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
-8?20$3;8T.P6BP^0"X9
M9K>]9!:G